Research strategy & organisation
Methodologically, our principal R&D strategy is to perform product development research directly in the human target organ, i.e. human skin or hair follicles, to stay as close as possible to clinical reality. We also use state-of-the-art in silico modelling for the identification of patentable actives.
Wherever possible, we favour skin & hair product development strategies that prioritize ecological sustainability, sourcing of natural compounds, product safety, high product value-for-money, and proven long-term skin/hair benefits.
Administratively, CUTANEON is located in Hamburg, Germany, while CUTANEON’s main research laboratory is located in the new “Biocube”, Berlin, Campus Berlin-Buch, one of Germany’s leading biotechnology hubs.
The Berlin laboratory is supported by a satellite laboratory in Sao Paulo, Brazil, to expand of CUTANEON’s scalp skin organ culture capacity and to access human skin of a wide range of ethnic origins.
Humanized mouse models (e.g., for alopecia areata, androgenetic alopecia, atopic dermatitis, skin rejuvenation) are run in close collaboration with Prof. Amos Gilhar, Technion Israel Institute, Haifa. Prof. Gilhar also serves as Medical Director of CUTANEON. At the academic level, CUTANEON closely collaborates with Prof. Paus’ lab at the University of Miami and with an international network of plastic surgeons, dermatologists, and hair transplant surgeons in Germany, the USA, Spain, and Israel.
CUTANEON has recently entered several strategic collaboration partnerships, e.g., with Bioneer Corp. / South Korea (topical siRNA), Olistic / Spain (hair nutraceuticals), and DermaliQ Therapeutics / Germany & USA (hair follicle-targeting topical vehicles), and Giuliani Investimenti, Luxembourg (cosmeceuticals, nutraceuticals, functional food).